ACSL4 and cardiomyopathy: In summary, our study provided novel insight into the pathological mechanisms of sepsis-induced cardiomyopathy, and miR-130b-3p /ACSL4 and miR-130b-3p /AMPK/mTOR signaling may be considered the new targets for the treatment of septic cardiomyopathy.